Skip to main content

Peer Review reports

From: Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials

Original Submission
2 May 2014 Submitted Original manuscript
12 May 2014 Reviewed Reviewer Report - Dorte Lisbet Nielsen
6 Jun 2014 Reviewed Reviewer Report - Marco Colleoni
16 Jul 2014 Author responded Author comments - Claire Barnard
Resubmission - Version 2
16 Jul 2014 Submitted Manuscript version 2
Publishing
17 Jul 2014 Editorially accepted
12 Aug 2014 Article published 10.1186/s12916-014-0132-3

You can find further information about peer review here.

Back to article page